NOVEL FOOD PENDING
STANDARDS
CBD & CBG UNLOCKED
We bring you the first dermo-genomics
study on CBD & CBG
23,000
Human genes (mRNA)
30,000
LincRNA
53
miRNA
Despite CBD’s success, its dermo-cosmetic efficacy had yet to be demonstrated and its modes of action identified. The Spectrums Europe study on Optima® CBD provides a complete mapping of its molecular signature in the skin.
Barrier function
enhancement
Antioxidant
protection
Chemo-
detoxification
Immuno
protection
Inflammation
modulation
CBG, cannabigerol, is the precursor molecule of all phytocannabinoids found in hemp. Very little was known about it. The study on Optima® CBG has unlocked its potential as a powerful anti-aging molecule with novel mode of actions.
Balanced cell
renewal
Autophagy
promotion
Antioxidant
protection
Inflammation
modulation
We know that skin aging or skin disorders are always the result of multiple causes and translate into complex interactions within the skin. Bringing proof of the systemic action of Optima® CBD and CBG while at the same time revealing original pathways (EVPLL, NMRAL2P, SP6, ...), Spectrums dermo-genomics study lays out the foundations of new skin care strategies.